Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Melda Yenerel"'
Autor:
Uğur Yayla, Mehmet Orkun Sevik, Veysel Levent Karabaş, Özlem Şahin, Abdullah Özkaya, Nursal Melda Yenerel, Banu Açıkalın Öncel, Fatih Bilgehan Kaplan, Ecem Önder Tokuç, Hatice Selen Kanar, Işıl Kutlutürk Karagöz, Ece Başaran Emengen, Ayşe Demirciler Sönmez, Aslan Aykut, Utku Limon, Erdinç Bozkurt, Işılay Özsoy Saygın, Tuğba Aydoğan Gezginaslan, Özlem Aydın Öncü, Esra Türkseven Kumral, Nimet Yeşim Erçalık, Erkan Çelik
Publikováno v:
Türk Oftalmoloji Dergisi, Vol 53, Iss 6, Pp 356-368 (2023)
Objectives: This study aimed to report the demographic and clinical characteristics of diabetic macular edema (DME) patients treated with intravitreal injection (IVI) of anti-vascular endothelial growth factors (anti-VEGF) and provide an overview of
Externí odkaz:
https://doaj.org/article/366bac1877524f1aba6d51d5c33e7bbc
Autor:
Alev Ozcelik-Kose, Serhat Imamoglu, Ali Aktekin, Sevcan Balci, Merve Beyza Yıldız, Yucel Ozturk, Nursal Melda Yenerel
Publikováno v:
Canadian Journal of Ophthalmology. 57:370-375
To examine the effect of bariatric surgery on the macular and peripapillary choroid in the late postoperative period in young patients with morbid obesity and compare them with a healthy control group.This prospective controlled study included 50 eye
Autor:
Esra Turkseven Kumral, Nimet Yesim Ercalık, Oksan Alpogan, Nursal Melda Yenerel, Alev Ozcelik Kose, Yucel Ozturk, Zeynep Ayse Acar
Publikováno v:
European Journal of Ophthalmology. 33:1061-1067
Purpose To evaluate and compare the retinal and choroidal spectral-domain optic coherence tomography (SD-OCT) findings of treatment-naïve diabetic macular edema (DME) secondary to non-proliferative and proliferative diabetic retinopathy (NPDR-PDR).
Publikováno v:
Batı Karadeniz Tıp Dergisi. 6:150-157
Amaç: Ranibizumab tedavisine dirençli tip 1 koroidal neovasküler membranlı olgularda intravitreal aflibercept tedavisinin etkinliğini araştırmak. Gereç ve Yöntemler: Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Göz Kliniği’ne Aral
Publikováno v:
Current Eye Research. 47:154-160
PURPOSE To compare peripapillary choroidal vascularity index (CVI) parameters in pseudoexfoliation glaucoma (PEG), pseudoexfoliation (PEX) syndrome, and healthy controls. METHODS A total of 240 eyes of 240 patients were included in this cross-section
Publikováno v:
Türk Oftalmoloji Dergisi, Vol 45, Iss 5, Pp 213-219 (2015)
Pregnancy causes significant changes in all systems of the body. Although most of them are physiological, they may also lead to pathological consequences. The resulting pathological changes may occur for the first time or existing diseases affected
Externí odkaz:
https://doaj.org/article/6f7f6234b5b04283913493f9974cda6c
Autor:
Raciha Beril Küçümen, Canan Aslı Utine, Ebru Görgün, Nursal Melda Yenerel, Şule Ziylan, Ferda Çiftçi
Publikováno v:
Türk Oftalmoloji Dergisi, Vol 45, Iss 1, Pp 5-8 (2015)
Objectives: To investigate the tear film osmolarity in eyes with chronic blepharitis. Materials and Methods: Patients with symptomatic chronic blepharitis were included in the study. After ophthalmologic examination, tear osmolarity was measured. T
Externí odkaz:
https://doaj.org/article/7537e08bb69d4ba0bbc60a6445418601
Autor:
Serhat Mangan, Mehmet, Bolac, Ruveyde, Beyza Yildiz, Merve, Imamoglu, Serhat, Turan Vural, Ece, Melda Yenerel, Nursal
Publikováno v:
Arquivos Brasileiros de Oftalmologia; 2023, Vol. 86 Issue 3, p263-269, 7p
Autor:
Alev Ozcelik, Kose, Mehmet Serhat, Mangan, Sevcan Yildiz, Balci, Nursal Melda, Yenerel, Serhat, Imamoglu, Hatice, Tekcan
Publikováno v:
Beyoglu eye journal. 7(3)
The purpose of the study was to evaluate the sudden visual loss and central 10-degree visual field (VF) change following glaucoma surgery in eyes with severe and end-stage glaucoma.This was a single-center retrospective study. The charts of patients
Publikováno v:
Beyoglu eye journal. 7(3)
The aim of the study was to compare ranibizumab treatment response of macular edema secondary to superior and inferior temporal branch retinal vein occlusion.Sixty-four eyes of 64 patients treated with 0.5 mg/0.05 mL ranibizumab due to macular edema